Gilles Gagnon

Gilles Gagnon

Chief Executive Officer at CEAPRO INC.

Net worth: 83 924 $ as of 2026-05-30

72 year
Health Technology
Commercial Services
Consumer Services

Profile

Gilles R.
Gagnon
is the founder of Prodev Pharma, Inc., founded in 2007, serving as President.
Current jobs include President, Chief Executive Officer & Director at Ceapro, Inc. since 2012; Chairman at JuventeDC, Inc.; Member at the Institute of Corporate Directors; and Member at Innovative Medicines Canada.
Former jobs include President & Chief Executive Officer at Æterna Zentaris, Inc. from 1999 to 2007; Chairman at BioQuebec; Independent Non-Executive Director at Spectrum Pharmaceuticals, Inc.; Executive Director at Warnex, Inc. in 2010; Director-Professional Services at Sandoz Pharmaceuticals Corp.
from 1989 to 1996; Director at Montreal Invivo Organization; Director at Sherbrooke Innopole; Independent Director at Æterna Zentaris, Inc. from 2020 to 2024; Director at COSCIENS Biopharma, Inc. in 2025; President at Spectrum Pharma Canada, Inc. from 2008 to 2015; and Vice President-External Affairs at Novartis Pharma Canada, Inc. from 1996 to 1999.
Education includes graduate and MBA degrees from the University of Sherbrooke.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
1.32%
2025-01-02 41,962 ( 1.32% ) 83 924 $ 2026-05-30

Gilles Gagnon active positions

CompaniesPositionStart
CEAPRO INC. Chief Executive Officer 2012-06-20
Corporate Officer/Principal -
Corporate Officer/Principal -
Chairman -
Founder 2007-04-30

Former positions of Gilles Gagnon

CompaniesPositionEnd
President 2014-12-31
Chairman 2013-02-27
Chief Executive Officer 2007-03-25
Novartis Pharma Canada, Inc.
Corporate Officer/Principal 1998-12-31
See the detail of Gilles Gagnon's experience

Training of Gilles Gagnon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

70

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Sandoz Pharmaceuticals Corp.

Distribution Services

Commercial Services

Health Technology

Commercial Services

Novartis Pharma Canada, Inc.

Retail Trade